SCIENCES & IMPACTS
 
 NEWS & EVENTS
 
  SCIENTIFIC MEETINGS IN RCPN (SMIR)
 »  Please click here to follow the SMIR news and events
 
  e-Learning In RCPN (eLIR)
 »  Please click here to follow the e-Learning In RCPN (eLIR)
 
 STAY CONNECTED
 » Research Center for Pharmaceutical Nanotechnology, Research and Development Complex, Tabriz University of Medical Sciences, Daneshgah street, Tabriz, IRAN. Postal Code: 5165665811
    DIRECTIONS

T +98 (41) 33367914
F +98 (41) 33367929  
E nano@tbzmed.ac.ir



 
  Intelligent drug delivery/diagnostics nanosystems
ano

Technical approach

Research leader

Research assistants

Post-doc researchers

Students

Selected publications

 

Intelligent drug delivery/diagnostics nanosystems 

In nanobiomedicine lab the researchers bring together bioengineering, pharmacology and nanotechnology and translate them to advanced, clinically-relevant therapeutics and diagnostics. The biological and clinical effects of prepared nonoparticles and their  interactions with living organisms evaluated at molecular and cellular level using a wide range of biological techniques. As another important research area, phage display technology has been developed for construction of various phage display libraries (peptide, scFv/Fab antibody and nanobodies libraries), production of fully human mAbs and Ab fragments, nanobodies and nanovaccines with applications in drug and target discovery, site-specific targeting of nanocarriers and imaging.


Technical approach

Real time PCR
Western blotting
Immunohistochemistry
Genotoxicity & Cytotoxicity analysis



Research Leader 


Prof.Jaleh Barar,(PharmD, PhD)
Dr. Ayuob Aghanejad, (M.Sc, Ph.D)
Dr. Morteza Eskandani
(M.Sc, Ph.D)
Dr. Fathi 
 (M.Sc, Ph.D)
Dr. Jafar Ezzati Nazhad Dolatabadi, PhD)
Dr. Aylar Nakhlband (M.Sc, Ph.D)
Professor.Yadollah Omidi, (PharmD, PhD)


Research Assistants

Asal golchin
Nazli saeidi


Post-doc researchers

Will be updated ASAP


PhD Students

 

 

Somayeh Vandghanooni received M.Sc (2007) of genetics and B.Sc of biology (2005) from the department of biology-genetic of Tabriz University. Her M.Sc project was about studying survivin gene expression and its splice variants as diagnostic biomarkers for malignant papillary thyroid tumors.  She was a member of exceptional talent organization during her education in both courses at university of Tabriz. She started her PhD in nanobiotechnology (2014) at Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran. Her PhD thesis is about the engineering of targeted drug delivery nanomachinery system for ovarian cancer chemo/gene therapy which is in progress under the supervision of Prof. Y. Omidi and Prof. J. Barar and advising of Dr. Eskandani.

 

 

 

 

Selected Publication based on scopus

Last two years publications (2017-2018)

 
1.         Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells. BioImpacts. 2018;8(2):117-27.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048082430&doi=10.15171%2fbi.2018.14&partnerID=40&md5=5f8a4a5ed2e47f4ada46ef978cfdd4a9

2.         Asghari S, Movafeghi A, Lisar SYS, Barar J, Omidi Y. Effects of phenanthrene on growth parameters and antioxidant systems in the green microalga chlorella vulgaris. Biointerface Research in Applied Chemistry. 2018;8(4):3405-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052365437&partnerID=40&md5=fdc89489e2d84bf2c4f97641305ed271

3.         Asgharzadeh MR, Barar J, Pourseif MM, Eskandani M, Niya MJ, Mashayekhi MR, et al. Molecular machineries of pH dysregulation in tumor microenvironment: Potential targets for cancer therapy. BioImpacts. 2017;7(2):115-33.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027460324&doi=10.15171%2fbi.2017.15&partnerID=40&md5=0829735dfa89423eb093a6fc07cea2ec

4.         Bakhtiary Z, Barar J, Aghanejad A, Saei AA, Nemati E, Ezzati Nazhad Dolatabadi J, et al. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Drug Development and Industrial Pharmacy. 2017;43(8):1244-53.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017243891&doi=10.1080%2f03639045.2017.1310223&partnerID=40&md5=a3a4450cf9f6ed9163e9604b2ef7c165

5.         Borran AA, Aghanejad A, Farajollahi A, Barar J, Omidi Y. Gold nanoparticles for radiosensitizing and imaging of cancer cells. Radiation Physics and Chemistry. 2018;152:137-44.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052432811&doi=10.1016%2fj.radphyschem.2018.08.010&partnerID=40&md5=3541b56118a7bcedc235d59528aac342

6.         Dehghani J, Movafeghi A, Barzegari A, Barar J. Efficient and stable transformation of Dunaliella pseudosalina by 3 strains of Agrobacterium tumefaciens. BioImpacts. 2017;7(4):247-54.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040972974&doi=10.15171%2fbi.2017.29&partnerID=40&md5=aa64a669a7400f1e82b6567501c8a118

7.         Eskandani M, Vandghanooni S, Barar J, Nazemiyeh H, Omidi Y. Cell physiology regulation by hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells. International Journal of Biological Macromolecules. 2017;99:46-62.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013761924&doi=10.1016%2fj.ijbiomac.2016.10.113&partnerID=40&md5=4d609bc880884abb22a518041b6a9202

8.         Fahimi F, Sarhaddi S, Fouladi M, Samadi N, Sadeghi J, Golchin A, et al. Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori. Applied Microbiology and Biotechnology. 2018;102(16):6899-913.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047945292&doi=10.1007%2fs00253-018-9068-4&partnerID=40&md5=9865ce9575ce57fa5aa503cc230c58cc

9.         Fathi M, Barar J. Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors. BioImpacts. 2017;7(1):49-57.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019106716&doi=10.15171%2fbi.2017.07&partnerID=40&md5=7703d2c4768923772ad87890004d1c99

10.       Fathi M, Majidi S, Zangabad PS, Barar J, Erfan-Niya H, Omidi Y. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Medicinal Research Reviews. 2018;38(6):2110-36.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047824876&doi=10.1002%2fmed.21506&partnerID=40&md5=2566096631e3941d12b78325dd476100

11.       Fathi M, Sahandi Zangabad P, Barar J, Aghanejad A, Erfan-Niya H, Omidi Y. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib. International Journal of Biological Macromolecules. 2018;106:266-76.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027684914&doi=10.1016%2fj.ijbiomac.2017.08.020&partnerID=40&md5=e863c26424866b7f5d93d67e01215d6f

12.       Fathi M, Zangabad PS, Aghanejad A, Barar J, Erfan-Niya H, Omidi Y. Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib. Carbohydrate Polymers. 2017;172:130-41.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019350573&doi=10.1016%2fj.carbpol.2017.05.007&partnerID=40&md5=14fbcf7b855cc5fa0b6748f93b7f9e81

13.       Fathi M, Zangabad PS, Majidi S, Barar J, Erfan-Niya H, Omidi Y. Stimuli-responsive chitosan-based nanocarriers for cancer therapy. BioImpacts. 2017;7(4):269-77.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041008382&doi=10.15171%2fbi.2017.32&partnerID=40&md5=a3481207a7941102508acbaa32214868

14.       Jafarizad A, Aghanejad A, Sevim M, Metin Ö, Barar J, Omidi Y, et al. Gold Nanoparticles and Reduced Graphene Oxide-Gold Nanoparticle Composite Materials as Covalent Drug Delivery Systems for Breast Cancer Treatment. ChemistrySelect. 2017;2(23):6663-72.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041836352&doi=10.1002%2fslct.201701178&partnerID=40&md5=6b0fbea4224f638561de41f6c3d258db

15.       Jaymand M, Lotfi M, Barar J, Kimyai S. Synthesis and characterization of potential multifunctional methacrylate-based dental monomers. Research on Chemical Intermediates. 2017;43(10):5707-22.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018402247&doi=10.1007%2fs11164-017-2957-9&partnerID=40&md5=505a2cab32a322b830ab80a77dbd675a

16.       Johari-Ahar M, Barar J, Karami P, Asgari D, Davaran S, Rashidi MR. Nafion-coated cadmium pentacyanonitrosylferrate-modified glassy carbon electrode for detection of dopamine in biological samples. BioImpacts. 2018;8(4):263-70.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056094508&doi=10.15171%2fbi.2018.29&partnerID=40&md5=f2d13690fa8ee38450dfbff42417e0a4

17.       Karami P, Majidi MR, Johari-Ahar M, Barar J, Omidi Y. Development of screen-printed tryptophan-kynurenine immunosensor for in vitro assay of kynurenine-mediated immunosuppression effect of cancer cells on activated T-cells. Biosensors and Bioelectronics. 2017;92:287-93.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006493516&doi=10.1016%2fj.bios.2016.11.010&partnerID=40&md5=edf3bfa31406b3199bdbafafe9ee161f

18.       Maleki Kakelar H, Barzegari A, Dehghani J, Hanifian S, Saeedi N, Barar J, et al. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer. 2018.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052663819&doi=10.1007%2fs10120-018-0867-1&partnerID=40&md5=001fe9f33fed1270945f9b525363283a

19.       Mesgari-Shadi A, Sarrafzadeh MH, Barar J, Omidi Y. Cost-effective batch production process of scFv antibody in Escherichia coli. Human Antibodies. 2017;26(3):149-57.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047346843&doi=10.3233%2fHAB-180333&partnerID=40&md5=915f30b6a94c90f2b0f4346a9193cd20

20.       Mesgari-Shadi A, Sarrafzadeh MH, Divband B, Barar J, Omidi Y. Batch adsorption/desorption for purification of scFv antibodies using nanozeolite microspheres. Microporous and Mesoporous Materials. 2018;264:167-75.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041469002&doi=10.1016%2fj.micromeso.2018.01.028&partnerID=40&md5=28865cc8862f3d164597a2826580f3f9

21.       Movahhedin N, Nazemiyeh H, Barar J, Esnaashari S, Movahhedin AH. Chemical constituent and biological activities of spatoglossum asperum J. Agardh from Oman sea. Letters in Drug Design and Discovery. 2018;15(3):263-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042144419&doi=10.2174%2f1570180814666170407103936&partnerID=40&md5=f1facf3f7310b892fdf34723e9fa0749

22.       Nakhlband A, Eskandani M, Omidi Y, Saeedi N, Ghaffari S, Barar J, et al. Combating atherosclerosis with targeted nanomedicines: Recent advances and future prospective. BioImpacts. 2018;8(1):59-75.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044298919&doi=10.15171%2fbi.2018.08&partnerID=40&md5=c44d352eea40fe79a5840b756e3d8c49

23.       Nakhlband A, Eskandani M, Saeedi N, Ghafari S, Omidi Y, Barar J, et al. Marrubiin-loaded solid lipid nanoparticles’ impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect. Colloids and Surfaces B: Biointerfaces. 2018;164:299-307.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041484199&doi=10.1016%2fj.colsurfb.2018.01.046&partnerID=40&md5=75a93e53a55737af8ff5751d49c96e8d

24.       Rahmanian N, Eskandani M, Barar J, Omidi Y. Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines. Journal of Drug Targeting. 2017;25(3):202-15.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013790692&doi=10.1080%2f1061186X.2016.1238475&partnerID=40&md5=bd598c4cfefb872b3e2a2475014d55e9

25.       Safary A, Khiavi MA, Mousavi R, Barar J, Rafi MA. Enzyme replacement therapies: What is the best option? BioImpacts. 2018;8(3):153-7.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050655722&doi=10.15171%2fbi.2018.17&partnerID=40&md5=2be2cddf621c4edf67048c83097c1868

26.       Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Jelvehgari M. Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies. Colloids and Surfaces B: Biointerfaces. 2017;159:629-38.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028508985&doi=10.1016%2fj.colsurfb.2017.08.031&partnerID=40&md5=68c1dd67244c51e07eb2882143dcee1e

27.       Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Kiafar F, Jelvehgari M. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Research in Pharmaceutical Sciences. 2017;12(1):1-14.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011407768&doi=10.4103%2f1735-5362.199041&partnerID=40&md5=1ca3ede71e64208420e39eaf976e037f

28.       Sattari M, Fathi M, Daei M, Erfan-Niya H, Barar J, Entezami AA. Thermoresponsive graphene oxide - Starch micro/nanohydrogel composite as biocompatible drug delivery system. BioImpacts. 2017;7(3):167-75.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032034810&doi=10.15171%2fbi.2017.20&partnerID=40&md5=c5df2c2ec842967197992737926392b9

29.       Tohidkia MR, Sepehri M, Khajeh S, Barar J, Omidi Y. Improved Soluble ScFv ELISA Screening Approach for Antibody Discovery Using Phage Display Technology. SLAS Discovery. 2017;22(8):1026-34.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019103807&doi=10.1177%2f2472555217701059&partnerID=40&md5=af31b18c9d2b27f21c12bcabf6ab2098

30.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells. Nanomedicine. 2018;13(21).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056644400&doi=10.2217%2fnnm-2018-0205&partnerID=40&md5=161fbb8b5bb78dce38d0ba61eedafcd7

31.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective. Journal of Molecular Medicine. 2018;96(9):885-902.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050732999&doi=10.1007%2fs00109-018-1669-y&partnerID=40&md5=74c22af238864e7d1d869770b489bc80

32.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer. European Journal of Pharmaceutical Sciences. 2018;117:301-12.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043258625&doi=10.1016%2fj.ejps.2018.02.027&partnerID=40&md5=dd05d32378ddc2b49636836862d6604b

33.       Zamanlu M, Farhoudi M, Eskandani M, Mahmoudi J, Barar J, Rafi M, et al. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. Journal of Drug Targeting. 2018;26(2):95-109.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041324095&doi=10.1080%2f1061186X.2017.1365874&partnerID=40&md5=89cb1d43d0465373462ee13f3fda5150

34.       Arteshi Y, Aghanejad A, Davaran S, Omidi Y. Biocompatible and electroconductive polyaniline-based biomaterials for electrical stimulation. European Polymer Journal. 2018;108:150-70.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052655195&doi=10.1016%2fj.eurpolymj.2018.08.036&partnerID=40&md5=2ee775b9cc2c2beb4aacd3f11134e449

35.       Fakhari A, Aghanejad A, Jalilian AR, Gharepapagh E. Recent developments in targeted imaging of CXCR4-chemokine receptor. Journal of Radioanalytical and Nuclear Chemistry. 2018;317(1).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046710240&doi=10.1007%2fs10967-018-5910-5&partnerID=40&md5=60a931532286b9856d0ef9a3807df3a8

36.       Khajeh S, Tohidkia MR, Aghanejad A, Mehdipour T, Fathi F, Omidi Y. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells. Artificial Cells, Nanomedicine and Biotechnology. 2018:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048189454&doi=10.1080%2f21691401.2018.1478846&partnerID=40&md5=c380e2f8405070fb03565a8153786c0c

37.       Abbasian M, Roudi MM, Mahmoodzadeh F, Eskandani M, Jaymand M. Chitosan-grafted-poly(methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem. International Journal of Biological Macromolecules. 2018;118:1871-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050084919&doi=10.1016%2fj.ijbiomac.2018.07.036&partnerID=40&md5=33428681c4201bab9082c7bb941cc54b

38.       Ahani N, Sangtarash MH, Houshmand M, Eskandani MA. Genipin induces cell death via intrinsic apoptosis pathways in human glioblastoma cells. Journal of Cellular Biochemistry. 2018.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052794062&doi=10.1002%2fjcb.27512&partnerID=40&md5=410af271da807892a0ed764b02e6e5d0

39.       Ahmadi R, Eskandani MA, Saadati D. Evaluation of antimicrobial effect of Iranian sumac on Bacillus cereus in a commercial barley soup. Slovenian Veterinary Research. 2017;54(2):65-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021950210&partnerID=40&md5=95ed0184d45c16ac129fc23c94737677

40.       Alizadeh N, Eskandani M, Tondro K, Rashidi MR, Nazemiyeh H. Inhibitory effects of flavonolignans from silybum marianum (L.) gaertn (milk thistle) on function of aldehyde oxidase and xanthine oxidase in rats. Letters in Drug Design and Discovery. 2018;15(3):256-62.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042142636&doi=10.2174%2f1570180814666170420110005&partnerID=40&md5=9d7d71936d1119d1160c37f0e2f402ea

41.       Anvari D, Saadati D, Nabavi R, Alipour Eskandani M. Epidemiology and molecular prevalence of Toxoplasma gondii in cattle Slaughtered in Zahedan and Zabol Districts, South East of Iran. Iranian Journal of Parasitology. 2018;13(1):114-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044081224&partnerID=40&md5=92e5d9883fc9d43ae8b4ca4b0333f6e2

42.       Bahadori MB, Eskandani M, De Mieri M, Hamburger M, Nazemiyeh H. Anti-proliferative activity-guided isolation of clerodermic acid from Salvia nemorosa L.: Geno/cytotoxicity and hypoxia-mediated mechanism of action. Food and Chemical Toxicology. 2018;120:155-63.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049924390&doi=10.1016%2fj.fct.2018.06.060&partnerID=40&md5=173289da0f078ba950820cc051e3b2a1

43.       Hamishehkar H, Bahadori MB, Vandghanooni S, Eskandani M, Nakhlband A, Eskandani M. Preparation, characterization and anti-proliferative effects of sclareol-loaded solid lipid nanoparticles on A549 human lung epithelial cancer cells. Journal of Drug Delivery Science and Technology. 2018;45:272-80.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044114825&doi=10.1016%2fj.jddst.2018.02.017&partnerID=40&md5=cb4a29ff0068898cf3beef801b1e5554

44.       Jafarizad A, Taghizadehgh-Alehjougi A, Eskandani M, Hatamzadeh M, Abbasian M, Mohammad-Rezaei R, et al. PEGylated graphene oxide/Fe<inf>3</inf>O<inf>4</inf>site: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem. Bio-Medical Materials and Engineering. 2018;29(2):177-90.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043572640&doi=10.3233%2fBME-171721&partnerID=40&md5=604dbe0eba079c4e81465ea27928fcea

45.       Nazemi K, Salari S, Eskandani MA. Assessment of the escherichia coli pollution in drinking water and water sources in sistan, iran. Journal of Water Reuse and Desalination. 2018;8(3):386-92.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047217532&doi=10.2166%2fwrd.2017.146&partnerID=40&md5=ec1779bc5da8845e7ab73a5b0bfe6a6d

46.       Ranjbar-Navazi Z, Eskandani M, Johari-Ahar M, Nemati A, Akbari H, Davaran S, et al. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy. Journal of Drug Targeting. 2018;26(3):267-77.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028533760&doi=10.1080%2f1061186X.2017.1365876&partnerID=40&md5=ecb973a8ad3ac8a67a759bfe5c6554a7

47.       Salmanzadeh R, Eskandani M, Mokhtarzadeh A, Vandghanooni S, Ilghami R, Maleki H, et al. Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics. Food Bioscience. 2018;24:37-45.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047079935&doi=10.1016%2fj.fbio.2018.05.005&partnerID=40&md5=86ec63b293c96c30b9a73dbb9b725882

48.       Soleymani J, Hasanzadeh M, Eskandani M, Khoubnasabjafari M, Shadjou N, Jouyban A. Electrochemical sensing of doxorubicin in unprocessed whole blood, cell lysate, and human plasma samples using thin film of poly-arginine modified glassy carbon electrode. Materials Science and Engineering C. 2017;77:790-802.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017176609&doi=10.1016%2fj.msec.2017.03.257&partnerID=40&md5=2cc028e231470e8bc56f40af9a154c01

49.       Zamanlu M, Eskandani M, Mohammadian R, Entekhabi N, Rafi M, Farhoudi M. Spectrophotometric analysis of thrombolytic activity: SATA assay. BioImpacts. 2018;8(1):31-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044265885&doi=10.15171%2fbi.2018.05&partnerID=40&md5=2d24d7004554008421046a67dbbc318a

50.       Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Applied Materials Today. 2018;12:177-90.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047632559&doi=10.1016%2fj.apmt.2018.05.002&partnerID=40&md5=85be4dc962da46c894694336e3396a14

51.       Dehghan P, Mohammadi A, Mohammadzadeh-Aghdash H, Ezzati Nazhad Dolatabadi J. Pharmacokinetic and toxicological aspects of potassium sorbate food additive and its constituents. Trends in Food Science and Technology. 2018;80:123-30.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051638167&doi=10.1016%2fj.tifs.2018.07.012&partnerID=40&md5=666ac685a26e4d1f7a010c506fcce750

52.       Ezzati Nazhad Dolatabadi J, Azami A, Mohammadi A, Hamishehkar H, Panahi-Azar V, Rahbar Saadat Y, et al. Formulation, characterization and cytotoxicity evaluation of ketotifen-loaded nanostructured lipid carriers. Journal of Drug Delivery Science and Technology. 2018;46:268-73.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047490981&doi=10.1016%2fj.jddst.2018.05.017&partnerID=40&md5=df51a638ae6170881bf6a1c19b00e2dc

53.       Fathi F, Mohammadzadeh-Aghdash H, Sohrabi Y, Dehghan P, Ezzati Nazhad Dolatabadi J. Kinetic and thermodynamic studies of bovine serum albumin interaction with ascorbyl palmitate and ascorbyl stearate food additives using surface plasmon resonance. Food Chemistry. 2018;246:228-32.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033370468&doi=10.1016%2fj.foodchem.2017.11.023&partnerID=40&md5=bc1c27f8821b0f93a8c4a28c8522212a

54.       Ghaffari M, Dehghan G, Abedi-Gaballu F, Kashanian S, Baradaran B, Ezzati Nazhad Dolatabadi J, et al. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting. European Journal of Pharmaceutical Sciences. 2018;122:311-30.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049783524&doi=10.1016%2fj.ejps.2018.07.020&partnerID=40&md5=8a5d58d99a904eb52c393319bcf6c088

55.       Mohammadzadeh-Aghdash H, Ezzati Nazhad Dolatabadi J, Dehghan P, Panahi-Azar V, Barzegar A. Multi-spectroscopic and molecular modeling studies of bovine serum albumin interaction with sodium acetate food additive. Food Chemistry. 2017;228:265-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012157908&doi=10.1016%2fj.foodchem.2017.01.149&partnerID=40&md5=d2ba24ee5a0319a9daccb05e3e46ff7e

56.       Mohammadzadeh-Aghdash H, Sohrabi Y, Mohammadi A, Shanehbandi D, Dehghan P, Ezzati Nazhad Dolatabadi J. Safety assessment of sodium acetate, sodium diacetate and potassium sorbate food additives. Food Chemistry. 2018;257:211-5.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043377618&doi=10.1016%2fj.foodchem.2018.03.020&partnerID=40&md5=26bd59039754951693116f055a43744a

57.       Mohammadzadeh-Asl S, Keshtkar A, Ezzati Nazhad Dolatabadi J, de la Guardia M. Nanomaterials and phase sensitive based signal enhancment in surface plasmon resonance. Biosensors and Bioelectronics. 2018;110:118-31.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044509764&doi=10.1016%2fj.bios.2018.03.051&partnerID=40&md5=5c3b8303c91c58df3fbed0f5b0039441

58.       Nemati E, Azami A, Mokhtarzadeh A, Rahbar Saadat Y, Omidi Y, Ezzati Nazhad Dolatabadi J. Formulation and characterization of ethambutol loaded nanostructured lipid carrier. Latin American Journal of Pharmacy. 2017;36(2):247-52.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009188311&partnerID=40&md5=0dd9090004b9a8389b901191bc5aa7b0

59.       Rafipour R, Kashanian S, Hashemi S, Omidfar K, Ezzati Nazhad Dolatabadi J. Apoferritin-templated biosynthesis of manganese nanoparticles and investigation of direct electron transfer of MnNPs–HsAFr at modified glassy carbon electrode. Biotechnology and Applied Biochemistry. 2017;64(1):110-6.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963957201&doi=10.1002%2fbab.1466&partnerID=40&md5=b60c70dc98dfef7be969316b4a43ce35

60.       Taghipour P, Zakariazadeh M, Sharifi M, Ezzati Nazhad Dolatabadi J, Barzegar A. Bovine serum albumin binding study to erlotinib using surface plasmon resonance and molecular docking methods. Journal of Photochemistry and Photobiology B: Biology. 2018;183:11-5.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045654843&doi=10.1016%2fj.jphotobiol.2018.04.008&partnerID=40&md5=9f17854f68968e8ed804b68c6e3ffcab

61.       Janani M, Jafari F, Samiei M, Lotfipour F, Nakhlband A, Ghasemi N, et al. Evaluation of antibacterial efficacy of photodynamic therapy vs. 2.5% NaOCl against E. faecalis-infected root canals using real-time PCR technique. Journal of Clinical and Experimental Dentistry. 2017;9(4):e539-e44.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016786368&doi=10.4317%2fjced.53526&partnerID=40&md5=df7cc5ea6ea274305a435299d226b189

62.       Nezhadhaghighi MG, Nakhlband A. Modeling and statistical analysis of non-Gaussian random fields with heavy-tailed distributions. Physical Review E. 2017;95(4).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017106915&doi=10.1103%2fPhysRevE.95.042114&partnerID=40&md5=b458724462918315430718d24f7b7664

63.       Abdollahi-Aghdam A, Majidi MR, Omidi Y. Microfluidic paper-based analytical devices (µPADs) for fast and ultrasensitive sensing of biomarkers and monitoring of diseases. BioImpacts. 2018;8(4):237-40.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056101467&doi=10.15171%2fbi.2018.26&partnerID=40&md5=c674c653dbde0f25069a0698908ef29a

64.       Akbari Nakhjavani S, Khalilzadeh B, Samadi Pakchin P, Saber R, Ghahremani MH, Omidi Y. A highly sensitive and reliable detection of CA15-3 in patient plasma with electrochemical biosensor labeled with magnetic beads. Biosensors and Bioelectronics. 2018;122:8-15.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053379901&doi=10.1016%2fj.bios.2018.08.047&partnerID=40&md5=c925ecd2ebd8ae18c0a362c531e6c248

65.       Asoudeh-Fard A, Barzegari A, Dehnad A, Bastani S, Golchin A, Omidi Y. Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signaling pathways. BioImpacts. 2017;7(3):193-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032022290&doi=10.15171%2fbi.2017.22&partnerID=40&md5=ac2f9710e0d21efbaf6eadd4a80bb0ae

66.       Daryanoosh M, Goudarzi G, Rashidi R, Keishams F, Hopke PK, Mohammadi MJ, et al. Risk of morbidity attributed to ambient PM<inf>10</inf>in the western cities of Iran. Toxin Reviews. 2017:1-6.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029411025&doi=10.1080%2f15569543.2017.1370602&partnerID=40&md5=af4f94f3f2ce72fc53ab7f47143e422a

67.       Dehghani J, Adibkia K, Movafeghi A, Barzegari A, Pourseif MM, Maleki Kakelar H, et al. Stable transformation of Spirulina (Arthrospira) platensis: a promising microalga for production of edible vaccines. Applied Microbiology and Biotechnology. 2018;102(21):9267-78.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052698199&doi=10.1007%2fs00253-018-9296-7&partnerID=40&md5=a973db2f6e09da62affb59742cc327ab

68.       Fahimi F, Tohidkia MR, Fouladi M, Aqabeigi R, Samadi N, Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. BioImpacts. 2017;7(1):59-71.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019068034&doi=10.15171%2fbi.2017.08&partnerID=40&md5=27df4ff00dca992299baaf7900741991

69.       Ferdousi R, Safdari R, Omidi Y. Computational prediction of drug-drug interactions based on drugs functional similarities. Journal of Biomedical Informatics. 2017;70:54-64.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019088981&doi=10.1016%2fj.jbi.2017.04.021&partnerID=40&md5=098782278979906f40d9f9cf2d2f249a

70.       Gharaati-Far N, Tohidkia MR, Dehnad A, Omidi Y. Efficiency and cytotoxicity analysis of cationic lipids-mediated gene transfection into AGS gastric cancer cells. Artificial Cells, Nanomedicine and Biotechnology. 2018;46(5):1001-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025432439&doi=10.1080%2f21691401.2017.1355311&partnerID=40&md5=a3cdfc55a52ef3259f8757b28e68e386

71.       Goudarzi G, Daryanoosh SM, Godini H, Hopke PK, Sicard P, De Marco A, et al. Health risk assessment of exposure to the Middle-Eastern Dust storms in the Iranian megacity of Kermanshah. Public Health. 2017;148:109-16.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018443434&doi=10.1016%2fj.puhe.2017.03.009&partnerID=40&md5=118cb4edffb7174767f7edb4c8ed3a79

72.       Mohammadi MJ, Yari AR, Saghazadeh M, Sobhanardakani S, Geravandi S, Afkar A, et al. A health risk assessment of heavy metals in people consuming Sohan in Qom, Iran. Toxin Reviews. 2017:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028539918&doi=10.1080%2f15569543.2017.1362655&partnerID=40&md5=b6fbf045c1c7b21deb47e9a81c6d4566

73.       Momtazan M, Geravandi S, Rastegarimehr B, Valipour A, Ranjbarzadeh A, Yari AR, et al. An investigation of particulate matter and relevant cardiovascular risks in Abadan and Khorramshahr in 2014–2016. Toxin Reviews. 2018:1-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045837160&doi=10.1080%2f15569543.2018.1463266&partnerID=40&md5=f22d5ddfffe0b78faf65bd8070f5854e

74.       Neisi A, Albooghobeish M, Geravandi S, Adeli Behrooz HR, Mahboubi M, Omidi Khaniabad Y, et al. Investigation of health risk assessment sevoflurane on indoor air quality in the operation room in Ahvaz city, Iran. Toxin Reviews. 2018:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042079259&doi=10.1080%2f15569543.2018.1434796&partnerID=40&md5=7743c13a195a1e81870c69af75f654d0

75.       Neisi A, Idani E, Vosoughi M, Hazrati S, Babaei AA, Takdastan A, et al. Answers to the comments on “Air pollution, biological marker and lung function in children”. Environmental Science and Pollution Research. 2018;25(27):27669-71.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051662886&doi=10.1007%2fs11356-018-2905-2&partnerID=40&md5=67ebae1b334f8ee7ae0b9613c4dbb3c5

76.       Omidi Khaniabadi Y, Sicard P, Omidi Khaniabadi A, Mohammadinejad S, Keishams F, Takdastan A, et al. Air quality modeling for health risk assessment of ambient PM<inf>10</inf>, PM<inf>2.5</inf> and SO<inf>2</inf> in Iran. Human and Ecological Risk Assessment. 2018.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056076901&doi=10.1080%2f10807039.2018.1487277&partnerID=40&md5=4ad5db9621bada963912faeefebe885c

77.       Pakchin PS, Nakhjavani SA, Saber R, Ghanbari H, Omidi Y. Recent advances in simultaneous electrochemical multi-analyte sensing platforms. TrAC - Trends in Analytical Chemistry. 2017;92:32-41.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019062608&doi=10.1016%2fj.trac.2017.04.010&partnerID=40&md5=86f1d82fb0a639bf442abe990251d8d4

78.       Panahpour H, Farhoudi M, Omidi Y, Mahmoudi J. An in vivo assessment of blood-brain barrier disruption in a rat model of ischemic stroke. Journal of Visualized Experiments. 2018;2018(133).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044652743&doi=10.3791%2f57156&partnerID=40&md5=3d54e84e447224149ceec28d52000563

79.       Parvizpour S, Razmara J, Omidi Y. Breast cancer vaccination comes to age: Impacts of bioinformatics. BioImpacts. 2018;8(3):223-35.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050689925&doi=10.15171%2fbi.2018.25&partnerID=40&md5=35bbff349a89fb1923d5cd2987fea1b2

80.       Pourseif MM, Moghaddam G, Daghighkia H, Nematollahi A, Omidi Y. A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus. BioImpacts. 2018;8(1):39-52.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044310762&doi=10.15171%2fbi.2018.06&partnerID=40&md5=ea0ff8f030d068035ab94721a89bd101

81.       Pourseif MM, Moghaddam G, Naghili B, Saeedi N, Parvizpour S, Nematollahi A, et al. A novel in silico minigene vaccine based on CD4+ T-helper and B-cell epitopes of EG95 isolates for vaccination against cystic echinococcosis. Computational Biology and Chemistry. 2018;72:150-63.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035245058&doi=10.1016%2fj.compbiolchem.2017.11.008&partnerID=40&md5=b0f720db7f8ae2e7b24b3291b687b69c

82.       Pourseif MM, Moghaddam G, Saeedi N, Barzegari A, Dehghani J, Omidi Y. Current status and future prospective of vaccine development against Echinococcus granulosus. Biologicals : journal of the International Association of Biological Standardization. 2018;51:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032934489&doi=10.1016%2fj.biologicals.2017.10.003&partnerID=40&md5=6e58b3fd4e237e6da7d3f19237f99091

83.       Rodriguez-Ruiz V, Salatti-Dorado JÁ, Barzegari A, Nicolas-Boluda A, Houaoui A, Caballo C, et al. Astaxanthin-loaded nanostructured lipid carriers for preservation of antioxidant activity. Molecules. 2018;23(10).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054802470&doi=10.3390%2fmolecules23102601&partnerID=40&md5=4c189dcfc787a799bb20b92924979f3d

84.       Samadi Pakchin P, Ghanbari H, Saber R, Omidi Y. Electrochemical immunosensor based on chitosan-gold nanoparticle/carbon nanotube as a platform and lactate oxidase as a label for detection of CA125 oncomarker. Biosensors and Bioelectronics. 2018;122:68-74.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053459986&doi=10.1016%2fj.bios.2018.09.016&partnerID=40&md5=4e7807561adf7ec2508472fd649146b5

85.       Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, et al. Fluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery. Drug Development and Industrial Pharmacy. 2017;43(8):1283-91.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017592278&doi=10.1080%2f03639045.2017.1313859&partnerID=40&md5=956a7b3a3d2c98a956bb934cd76db1fd

86.       Zeydouni G, Kianizadeh M, Omidi Khaniabadi Y, Nourmoradi H, Esmaeili S, Mohammadi MJ, et al. Eriochrme black-T removal from aqueous environment by surfactant modified clay: equilibrium, kinetic, isotherm, and thermodynamic studies. Toxin Reviews. 2018:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045213969&doi=10.1080%2f15569543.2018.1455214&partnerID=40&md5=2095548ed9344e26d9a044e28ea026b1

87.       Zeydouni G, Rodriguez Couto S, Nourmoradi H, Basiri H, Amoatey P, Esmaeili S, et al. H<inf>2</inf>SO<inf>4</inf>-modified Aloe vera leaf shells for the removal of P-chlorophenol and methylene blue from aqueous environment. Toxin Reviews. 2018:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049807048&doi=10.1080%2f15569543.2018.1478857&partnerID=40&md5=bdf7de5b7ece62088ae83ed875b9ce03

88.       Zununi Vahed S, Barzegari A, Rahbar Saadat Y, Goreyshi A, Omidi Y. Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways. Biomedicine and Pharmacotherapy. 2017;94:1094-100.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027844768&doi=10.1016%2fj.biopha.2017.08.033&partnerID=40&md5=d08e9c996121bc668e1cd915103e9429

89.       Zununi Vahed S, Moghaddas Sani H, Rahbar Saadat Y, Barzegari A, Omidi Y. Type 1 diabetes: Through the lens of human genome and metagenome interplay. Biomedicine and Pharmacotherapy. 2018;104:332-42.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047069658&doi=10.1016%2fj.biopha.2018.05.052&partnerID=40&md5=e7ec61ac2dd58c29426051bbb3577643

90.       Zununi Vahed S, Omidi Y, Ardalan M, Samadi N. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Clinical Biochemistry. 2017;50(1-2):32-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-84981743382&doi=10.1016%2fj.clinbiochem.2016.08.007&partnerID=40&md5=dce5e69110b5bc9c9653cc93e28cc807

91.       Zununi Vahed S, Poursadegh Zonouzi A, Ghanbarian H, Ghojazadeh M, Samadi N, Omidi Y, et al. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function. International Urology and Nephrology. 2017;49(9):1681-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018254073&doi=10.1007%2fs11255-017-1602-2&partnerID=40&md5=0d7967abbcfdfe2675a89d83f9394a92

92.       Zununi Vahed S, Poursadegh Zonouzi A, Mahmoodpoor F, Samadi N, Ardalan M, Omidi Y. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction. Archives of Medical Research. 2017;48(1):96-104.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020124194&doi=10.1016%2fj.arcmed.2017.03.004&partnerID=40&md5=bc4c9715013ee59126af3fcfd94c159b